Application of miR-495-5p in preparation of products for diagnosis, prognosis, prevention or treatment of pancreatic cancer
A technology for pancreatic cancer and pancreatic cancer cells, applied in the application field of the product, can solve the problem of unclear mode of action and related mechanisms
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Example 1: miR-495-5p is significantly abnormally expressed in pancreatic cancer cells
[0041] This example demonstrates that miR-495-5p is abnormally expressed in pancreatic cancer cells PANC-1 and BxPC-3 relative to normal pancreatic cells H6C7
[0042] 1. Extraction of total RNA from the sample
[0043] use Reagent (Invitrogen, Carlsbad, CA, USA) was used to extract RNA from normal pancreatic cell H6C7, pancreatic cancer cell PANC-1 and BxPC-3 samples, and the experimental operation was carried out according to the product manual. The specific operation was as follows:
[0044] Collect the samples and freeze them in liquid nitrogen. Take out about 30 mg of cell samples and place them in a pre-cooled mortar for grinding. After the cell samples are ground until no particles appear, follow the steps below:
[0045] ① Add Trizol and let stand at room temperature for 10 minutes;
[0046] ② Add 0.2 mL of chloroform, vibrate the centrifuge tube vigorously, mix well, a...
Embodiment 2
[0076] Example 2: Verification of the relationship between miR-495-5p and S100P target genes
[0077] This example proves that miR-495-5p can inhibit the expression of S100P.
[0078] 1. Design and synthesis of antisense oligonucleotides against miR-495-5p (anti-miR-495-5p)
[0079] According to the sequence information of miR-495-5p, the antisense oligonucleotide sequence and random control sequence of miR-495-5p were designed and synthesized by Guangzhou Ruibo Biotechnology Co., Ltd., and the antisense oligonucleotide of miR-495-5p ( miR-495-5p-inhibitor) sequence is shown in SEQ ID NO: 2 (CUUCAACGGGUACAAUAAAAGC).
[0080] 2. Transfection
[0081] The cationic liposome method was used for transient transfection, and the operation was performed according to Lipofectamine TM 2000 TransfectionReagent reagent instructions. Pancreatic cancer cells PANC-1 in good growth state were inoculated into 6-well plates 24 hours before transfection, and the cell count was about 5×10 4 ...
Embodiment 3
[0088] Example 3: Effects of inhibitors of miR-495-5p on the proliferation ability and cell cycle of pancreatic cancer cells PANC-1
[0089] Experimental groups: blank control group, negative control group, anti-miR-495-5p transfection experimental group.
[0090] Cells in the logarithmic growth phase were taken to form 1×10 4 / mL single cell suspension was inoculated in a 96-well plate, 100 μL per well, and 6 replicate wells were set up for each group. After the cells adhered to the wall, CCK-8 reagent was added, and the absorbance value at 450 nm wavelength was measured with a microplate reader after 2 hours as the zero point. After that, add 10 μL of CCK-8 reagent to each well and incubate for 2 hours every 24 hours for 5 consecutive days, measure the absorbance value of the cells with a microplate reader, and draw the cell proliferation curve. The result is as Figure 4 The results showed that compared with the control group, there was no significant difference in cell ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



